Unique ID issued by UMIN | UMIN000050701 |
---|---|
Receipt number | R000057755 |
Scientific Title | A Multicenter Randomized Controlled Trial Comparing With and Without Artificial Intelligence-based Intraoperative Image Navigation System Use in Laparoscopic Surgery |
Date of disclosure of the study information | 2023/03/31 |
Last modified on | 2023/03/28 15:15:54 |
Research to evaluate the usefulness of artificial intelligence-based surgical navigation systems
ImNavi trial
A Multicenter Randomized Controlled Trial Comparing With and Without Artificial Intelligence-based Intraoperative Image Navigation System Use in Laparoscopic Surgery
ImNavi trial
Japan |
colorectal tumor
Gastrointestinal surgery |
Malignancy
NO
To explore the benefit of intraoperative use of an artificial intelligence-based surgical anatomy navigation system in laparoscopic surgery.
Efficacy
Exploratory
Pragmatic
Phase II
the time required for each target organ to be recognized by surgeons after its initial appearance on the monitor.
intraoperative target organ injuries, intraoperative complications, operation time, blood loss, length of postoperative hospital stay, postoperative complications within 30 days, postoperative male sexual dysfunction at 1 month after surgery, surgeon's confidence in recognition of each target organ, and postoperative fatigue of the primary surgeon according to the Piper Fatigue Scale-12.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Device,equipment |
Perform the surgery as usual, and verbally declare that the target organ for recognition has appeared on the screen at the time it is recognized.
Perform the surgery using an AI-based navigation system, and the surgeon verbally declares this when he/she recognizes that the target organ for recognition has appeared on the screen.
18 | years-old | <= |
80 | years-old | >= |
Male and Female
Patients between 18 and 80 years of age, who are scheduled to undergo laparoscopic left-sided colorectal resection will be included in the ImNavi trial. As long-term outcomes are not included in the endpoints, patients with any colorectal diseases will be eligible.
Patients with emergent surgery, with expected intra-abdominal severe adhesion, with a significant anatomical anomaly, and deemed unsuitable by the doctor in charge will be excluded.
90
1st name | Masaaki |
Middle name | |
Last name | Ito |
National Cancer Center Hospital East
Department for the Promotion of Medical Device Innovation
277-8577
6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
0471331111
maito@east.ncc.go.jp
1st name | Daichi |
Middle name | |
Last name | Kitaguchi |
National Cancer Center Hospital East
Department for the Promotion of Medical Device Innovation
277-8577
6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
0471331111
dkitaguc@east.ncc.go.jp
National Cancer Center
Masaaki Ito
National Cancer Center
Japanese Governmental office
Japan
the institutional research ethics review board of the National Cancer Center Hospital
6-5-1, Kashiwanoha
0471331111
irst@ncc.go.jp
NO
2023 | Year | 03 | Month | 31 | Day |
Unpublished
Preinitiation
2023 | Year | 01 | Month | 20 | Day |
2023 | Year | 06 | Month | 20 | Day |
2025 | Year | 03 | Month | 31 | Day |
2023 | Year | 03 | Month | 28 | Day |
2023 | Year | 03 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057755